Showing results (1-10 of 270) with videos related to
Sort By:
Pageof 27
Thrombosis Research|August 1, 1994
How does ticlopidine treatment lower plasma fibrinogen?E Mazoyer, L Ripoll, M R Boisseau, et al.Archives Des Maladies Du Coeur Et Des Vaisseaux|December 2, 1998
[The role of thrombotic and hemostatic mechanisms in the initial phases of atherosclerosis]L Drouet, E Mazoyer, C Bal dit Sollier, et al.The British Journal of Nutrition|April 1, 1995
Characterization of an antithrombotic peptide from kappa-casein in newborn plasma after milk ingestionB Chabance, P Jollès, C Izquierdo, et al.Thrombosis Research|September 25, 1999
Risk factors and outcomes for atherothrombotic disease in French patients: the RIVAGE study. RIsque VAsculaire Group d'EtudeE Mazoyer, L Drouet, C Soria, et al.Thrombosis Research|November 5, 2002
D-dimer: a characteristic of the coagulation state of each patient with chronic atrial fibrillationI Mahé, L Drouet, O Chassany, et al.British Journal of Clinical Pharmacology|March 9, 2005
Paracetamol: a haemorrhagic risk factor in patients on warfarinI Mahé, N Bertrand, L Drouet, et al.Journal Des Maladies Vasculaires|April 25, 2001
[Are rheological markers of poor prognosis present in diabetic arteriopathies?]M R BoisseauJournal Des Maladies Vasculaires|May 1, 1997
[Venous valves in the legs: hemodynamic and biological problems and relationship to physiopathology]M R BoisseauScandinavian Journal of Clinical and Laboratory Investigation. Supplementum|January 1, 1981
Haematological and general factors influencing sieving. A general and prospective reviewM R BoisseauInternational Angiology : a Journal of the International Union of Angiology|January 8, 2003
Pharmacological targets of drugs employed in chronic venous and lymphatic insufficiencyM R BoisseauPageof 27